RaySearch Laboratories AB (publ) announces the release of the latest version of RayCare, the next generation oncology information system.

July 14, 2023 — RaySearch Laboratories AB (publ) announces the release of the latest version of RayCare*, the next generation oncology information system. RayCare 2023B* features a deeper and richer integration between RaySearch’s products than ever before and introduces support for specification of the radiotherapy treatment course in RayCare, improving usability and efficiency of treatment management. 

A key feature of RayCare 2023B is the enhanced fully integrated management of radiotherapy treatment courses from prescription to the review of treatment results in RayCare. A new dedicated workspace for treatment course management supports all user needs in relation to managing the fractionation schedule for treatments including assignment of plans, managing treatment settings and handling approvals. Combined with the digital workflow support and treatment scheduling capabilities in RayCare as well as the integration with RayStation, treatment management is made simpler and more efficient. 

RayCare 2023B features a deeper and richer integration than ever before between RaySearch’s products, supporting more automated data transfer and a more cohesive user experience throughout the radiotherapy flow. The enhanced design supports efficiency and safety in the clinical workflow by reducing the number of manual actions and having structured data readily available where needed at all steps. 

Other feature updates in this version include enhanced treatment schedules, support for more data migration as well as feature and usability updates to the patient chart and task management.  

Johan Löf, founder and CEO, RaySearch, says: “It is satisfying to see the increased interest for RayCare as well as more clinics using the products in their clinical routine. We continue to further develop the product at a high pace and this release marks an even more integrated solution with the rest of our products to provide an efficient and superior user experience.” 

* Subject to regulatory clearance in some markets. 

For more information: www.raysearchlabs.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Subscribe Now